Goeroptics Debuts Innovative AR Etching Waveguide and DLP 3D Printing Light Engine Module
SAN FRANCISCO,Feb. 6,2025-- Goertek Optics Technology Co. ("Goeroptics"),a subsidiary of Goertek,has unveiled its latest full-color augmented reality (AR) etching waveguidemodule,Star G-E1,a
Alumnus provides largest scholarship gift in university\'s history; Investment in the next generation of scientists and leaders comes at a time of global crisis
"Revolutionary portable device leverages advanced magnetic resonancetechnology to rapidly detect acute stroke biomarkers,enabling frontline care teams to make faster,life-saving decisions within
TCL CSOT Showcases Advanced Commercial Display Solutions at ISE 2025
BARCELONA,Spain,Feb. 6,2025-- TCL CSOT,a leading innovator in display technology,is set to present its comprehensive commercial display portfolio at Integrated Systems Europe (ISE) 2025,taking place f
NetEase Cloud Music Inc. to Report Fiscal Year 2024 Financial Results on February 20, 2025
HANGZHOU,China,Feb. 6,2025-- NetEase Cloud Music Inc. (HKEX: 9899 or the "Company"),a leading interactive music streaming service provider in China,today announced that it will report its fi
Silicon Motion First to Achieve ASPICE CL3 for Automotive SSD Controllers
TAIPEI and MILPITAS,Calif.,Feb. 6,2025--Silicon Motion Technology Corporation (NasdaqGS: SIMO) ("Silicon Motion"),a global leader in designing and marketing NAND flash controllers for solid
HONG KONG,Jan. 27,2025-- Akeso,Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting mono
QINGDAO,China,Jan. 26,2025-- Hisense,a leading brand in global consumer electronics and home appliances,has reinforced its dominance in the global TV market achieving an unprecedented three consecutiv
Seeking Investors: First-in-Class Immunotherapeutics for Cancer
ATLANTA,Jan. 27,2025-- Cambium Oncology is pleased to share that their lead drug candidate,ANT308,recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug i
ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
TOKYO,Jan. 28,2025-- ThinkCyte,a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments,announced today that it will begin the pre-commercial